公开(公告)号：US20120183607A1

公开(公告)日：2012-07-19

申请号：US13183119

申请日：2011-07-14

Applicant: Arno Appavoo ENOSE ,  Harish Kumar MADAN ,  Sumit MADAN ,  Anupam TREHAN ,  Puneet TYAGI ,  Vinod Kumar ARORA

Inventor： Arno Appavoo ENOSE ,  Harish Kumar MADAN ,  Sumit MADAN ,  Anupam TREHAN ,  Puneet TYAGI ,  Vinod Kumar ARORA

IPC: A61K9/48 ,  A61K9/28 ,  A61P33/06 ,  A61K31/496

CPC classification number: A61K45/06 ,  A61K9/1652 ,  A61K9/2027 ,  A61K9/2054 ,  A61K9/2077 ,  A61K9/2866 ,  A61K9/4866 ,  A61K31/335 ,  A61K31/357 ,  A61K31/4706 ,  A61K31/496 ,  A61K31/498 ,  C07D323/02 ,  C07D493/20 ,  A61K2300/00

Abstract: The field of the invention relates to stable dosage forms comprising spiro or dispiro 1,2,4-trioxolane antimalarials, or their pharmaceutically acceptable salts, prodrugs and analogues, and processes for their preparation. The water content of the dosage form is not more than 6.5% w/w.

Abstract translation: 本发明的领域涉及包含螺或脱甲基-1,2,4-三恶烷抗疟药物或其药学上可接受的盐，前药和类似物的稳定剂型及其制备方法。 剂型的含水量不超过6.5％w / w。

公开(公告)号：US20110172201A1

公开(公告)日：2011-07-14

申请号：US12997668

申请日：2009-06-12

Applicant: Vinod George ,  Bhupendra Vashishta ,  Mohan Prasad ,  Naresh Kumar ,  Vinod Kumar Arora

Inventor： Vinod George ,  Bhupendra Vashishta ,  Mohan Prasad ,  Naresh Kumar ,  Vinod Kumar Arora

IPC: A61K31/407 ,  C07D477/20 ,  A61P31/04

CPC classification number: A61K9/0019 ,  A61K9/19 ,  A61K31/407 ,  C07D477/20

Abstract: The present invention relates to a process for preparing a carbapenem antibiotic composition. The present invention further relates to a carbapenem antibiotic composition substantially free of degradation impurities. The present invention further relates to a polymorphic form of ertapenem mono sodium designated as Form D and its preparation.

Abstract translation: 本发明涉及一种制备碳青霉烯类抗生素组合物的方法。 本发明还涉及基本上不含降解杂质的碳青霉烯类抗生素组合物。 本发明还涉及被称为D型的ertapenem单钠的多晶形式及其制备方法。

公开(公告)号：US20090275660A1

公开(公告)日：2009-11-05

申请号：US12434499

申请日：2009-05-01

Applicant: Bhaskar CHAUHAN ,  Vinod Kumar Arora ,  Jyoti Srivastava

Inventor： Bhaskar CHAUHAN ,  Vinod Kumar Arora ,  Jyoti Srivastava

IPC: A61K31/195 ,  A61K31/16

CPC classification number: A61K31/65 ,  A61K9/0019 ,  A61K9/08 ,  A61K9/19

Abstract: The present invention relates to stable parenteral formulations of tigecycline and process of preparation thereof, wherein the formulation comprises of an edetate, a pH modifying agent or an antioxidant, such that the formulation remains stable for at least 45 hours.

Abstract translation: 本发明涉及替加环素的稳定的肠胃外制剂及其制备方法，其中所述制剂包含依地酸，pH调节剂或抗氧化剂，使得制剂保持稳定至少45小时。

公开(公告)号：US20190264959A1

公开(公告)日：2019-08-29

申请号：US16380127

申请日：2019-04-10

Applicant: Vinod Kumar Arora

Inventor： Vinod Kumar Arora

IPC: F25B29/00 ,  C01C1/04 ,  F25B7/00

Abstract: An improved performance ammonia plant system utilizing both a direct and indirect chilling of the compressed process air train using a single or multistage chilling system integrated with the ammonia plant ammonia compression train to increase process air flow to the secondary ammonia reformer of the ammonia plant.

公开(公告)号：US10302337B2

公开(公告)日：2019-05-28

申请号：US15682974

申请日：2017-08-22

Applicant: Vinod Kumar Arora

Inventor： Vinod Kumar Arora

IPC: C01C1/04 ,  F25B29/00 ,  F25B7/00

Abstract: An ammonia plant system upgrade utilizing both a direct and indirect multistage chilling system in the ammonia plant air compression train to increase process air flow to the secondary ammonia reformer of an ammonia plant as well as upgrades to provide more pre-heating along with increased process air flow.

公开(公告)号：US20120149720A1

公开(公告)日：2012-06-14

申请号：US13187798

申请日：2011-07-21

Applicant: Tarun GOSWAMI ,  Shashikanth P. ISLOOR ,  Vinod Kumar ARORA

Inventor： Tarun GOSWAMI ,  Shashikanth P. ISLOOR ,  Vinod Kumar ARORA

IPC: A61K31/522 ,  A61P31/22

CPC classification number: A61K31/522

Abstract: The present invention relates to taste-masked pharmaceutical formulations of valacyclovir. The present invention also relates to process of preparation of valacyclovir suspensions, solutions and dry powder for reconstitution.

Abstract translation: 本发明涉及伐昔洛韦的掩味药物制剂。 本发明还涉及制备伐昔洛韦悬浮液，溶液和干粉的重组方法。